4//SEC Filing
Sommadossi Jean-Pierre 4
Accession 0000899243-23-003615
CIK 0001593899other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 6:33 PM ET
Size
7.9 KB
Accession
0000899243-23-003615
Insider Transaction Report
Form 4
Sommadossi Jean-Pierre
DirectorPresident, CEO, and Chairman
Transactions
- Award
Restricted Stock Units
2023-01-31+520,400→ 520,400 total→ Common Stock (520,400 underlying) - Award
Stock Option (Right to Buy)
2023-01-31+728,600→ 728,600 totalExercise: $4.63Exp: 2033-01-30→ Common Stock (728,600 underlying)
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]The RSUs vest in three (3) equal annual installments on the first three anniversaries of the grant date such that the RSUs are fully vested on January 31, 2026.
- [F3]The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2023 such that the option is fully vested on January 31, 2027.
Documents
Issuer
Atea Pharmaceuticals, Inc.
CIK 0001593899
Entity typeother
Related Parties
1- filerCIK 0001296995
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 6:33 PM ET
- Size
- 7.9 KB